Hepion Pharmaceuticals Inc (HEPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,586 | 406 | 1,497 | 2,115 | 13,106 |
| Receivables | N/A | N/A | 600 | N/A | N/A |
| TOTAL | $6,319 | $1,614 | $3,530 | $5,482 | $15,430 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 185 | 107 | 138 |
| TOTAL | $N/A | $N/A | $185 | $107 | $138 |
| Total Assets | $6,319 | $1,614 | $3,715 | $6,010 | $15,989 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 149 |
| Accounts payable and accrued liabilities | 243 | 220 | 186 | 447 | 1,497 |
| Accrued Expenses | 167 | 24 | 306 | 375 | 794 |
| TOTAL | $936 | $3,144 | $2,716 | $976 | $2,574 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,487 | 333 | 1,406 | 1,473 | 5,894 |
| TOTAL | $1,487 | $333 | $1,406 | $1,473 | $5,894 |
| Total Liabilities | $2,423 | $3,477 | $4,122 | $2,448 | $8,468 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,976 | 10,975 | 139 | 116 | 109 |
| Common Shares | 1 | 0 | 1 | 1 | 1 |
| Retained earnings | -243,926 | -237,820 | -236,272 | -231,406 | -227,481 |
| Other shareholders' equity | 864 | 864 | 802 | 802 | 865 |
| TOTAL | $3,896 | $-1,863 | $-407 | $3,562 | $7,521 |
| Total Liabilities And Equity | $6,319 | $1,614 | $3,715 | $6,010 | $15,989 |